ZimVie Inc
NASDAQ:ZIMV
Net Margin
ZimVie Inc
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| US |
Z
|
ZimVie Inc
NASDAQ:ZIMV
|
250m USD |
-4%
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
230.9B USD |
32%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
191.5B USD |
28%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
154.4B USD |
12%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
149.2B USD |
12%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
110.5B USD |
14%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
52.4B EUR |
9%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
48.6B USD |
7%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
45.3B USD |
75%
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
42.6B USD |
23%
|
|
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
275.8B CNY |
31%
|
ZimVie Inc
Glance View
Zimvie, Inc. operates as a holding company, which engages in the manufacture, design, and distribution of medical devices and surgical instruments. The company is headquartered in Westminster, Colorado and currently employs 2,700 full-time employees. The company went IPO on 2022-02-14. The firm develops, manufactures, and markets a portfolio of products and solutions designed to treat a range of spine pathologies and support dental tooth replacement and restoration procedures. The Company’s operations are managed on a products basis and include two operating segments: the spine products segment, and the dental products segment. Its spine products segment focused on designing, manufacturing, and distributing medical devices and surgical instruments to deliver solutions for individuals with back or neck pain caused by degenerative conditions, deformities, tumors, or traumatic injury of the spine. Its product portfolio includes Mobi-C Cervical Disc and the Tether device. Its dental products segment is focused on designing, manufacturing and/or distributing of dental implant solutions. Its products include T3 Implant, Tapered Screw-Vent Implant System, Trabecular Metal Dental Implant, and BellaTek Encode Impression System.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on ZimVie Inc's most recent financial statements, the company has Net Margin of -4.4%.
You don't have any saved screeners yet